Multiple myeloma: lusting for NF-kappaB.

  title={Multiple myeloma: lusting for NF-kappaB.},
  author={Thomas D. Gilmore},
  journal={Cancer cell},
  volume={12 2},
Multiple myeloma (MM) is a late-stage B cell malignancy that has received much attention recently because of its therapeutic susceptibility to proteasome inhibitors. Two papers in this issue of Cancer Cell show that primary MM samples and MM cell lines frequently have mutations in genes encoding regulators and effectors of NF-kappaB signaling, and that these mutations lead to chronic NF-kappaB target gene expression, which is required for the viability of these MM tumor cells. These results… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 22 extracted citations

Similar Papers

Loading similar papers…